breast cancer Flashcards
breast cancer risk factors
early menarche late menopause nulliparous obesity chest radiation HHRT post menopause
breast cancer staging
stage 1: less than 2cm, no lymph node involvement
stage 2: 2 to 5cm with or without lymph nodes
stage 3: greater than 4 positive lymph nodes
stage 4: mets
Breast cancer screening
brca mutations
strong family history
Ductal carcinoma in situ
stage 0 cancer calcification on mamography surgical resection tamoxifen if estrogen receptor positive 97% surival at 15 years with therapy
invasive breast cancer therapy
breast conserving therapy - tumor 5cm or less
mastectomy
post surgical radiation therapy
breast cancer adjuvent endocrine therapy
eradicate microscopic disease
tamoxifen if estrogen receptor positive. longer therapy shown to be superior.
aromatase inhibitors- stop peripheral conversion of
androgens to estrogens. post menopausal only
tamoxifen
estrogen receptor blocker
used to to treat estrogen receptor positive breast cancer
increases risk of endometrial cancers
increases risk of thrombosis
aromatase inhibitors
anastrazole, letrozole
block peripheral conversion of androgens to estrogen
only used
breast cancer adjuvent chemotherapy
hormone receptor negative cancer
HER2 positive cancers
trastuzumab
monoclonal directed to her2 positive cells
added to adjuvent breast cancer therapy
risk of cardiomyopathy
breast cancer follow up
regular mamography